<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03759327</url>
  </required_header>
  <id_info>
    <org_study_id>AFH</org_study_id>
    <nct_id>NCT03759327</nct_id>
  </id_info>
  <brief_title>Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series</brief_title>
  <official_title>Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      single institution cases series review of histological and clinical data
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      single institution cases series review of histological and clinical data Investigators will
      retrieve from the archives of the Rizzoli Institute all the cases with a histological
      diagnosis of Angiomatoid Fibrous Histiocytoma. In all cases with enough available material,
      immunohistochemistry will be performed on slides/formalin-fixed paraffin-embedded tissue
      tumor material.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 30, 2018</start_date>
  <completion_date type="Actual">May 25, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>selection and review of 9 cases of Angiomatoid Fibrous Histiocytoma</measure>
    <time_frame>at baseline (Day0)</time_frame>
    <description>investigators will review all the medical records, radiological imaging, and histological slides of all cases to identify the best therapeutic approach.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>analysis of EWS-CREB1 and EWS-ATF1 mutation and ALK expression on tissue tumor material</measure>
    <time_frame>at baseline (Day0)</time_frame>
    <description>In all cases immunohistochemistry will be performed on slides/formalin-fixed paraffin-embedded tissue tumor material. EWS-CREB1 and EWS-ATF1 mutation and ALK expression will be analyzed with RT-PCR and/or FISH analysis.</description>
  </primary_outcome>
  <enrollment type="Actual">9</enrollment>
  <condition>Angiomatoid Fibrous Histiocytoma</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      immunohistochemistry will be performed on FFPE material. EWS-CREB1 and EWS-ATF1 mutation and
      ALK expression will be analyzed with RT-PCR and/or FISH analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male and Female with diagnosis of Angiomatoid Fibrous Histiocytoma with histological
        slides/formalin-fixed paraffin-embedded tissue tumor blocks from archive available to
        perform the histology analysis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients treated at Rizzoli Institute from 01 January 2006 to 31
             December 2017

          -  Diagnosis of Angiomatoid Fibrous Histiocytoma

          -  Histological slides/formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from
             archive available to perform the histology analysis

          -  Written informed consent prior to any study-specific analysis and/or data collection

        Exclusion Criteria:

        â€¢ Patients with histological diagnosis different from Angiomatoid Fibrous Histiocytoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>IRCC Rizzoli Orthopedic Institute</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, Ladanyi M. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007 Dec;46(12):1051-60.</citation>
    <PMID>17724745</PMID>
  </results_reference>
  <results_reference>
    <citation>Bohman SL, Goldblum JR, Rubin BP, Tanas MR, Billings SD. Angiomatoid fibrous histiocytoma: an expansion of the clinical and histological spectrum. Pathology. 2014 Apr;46(3):199-204. doi: 10.1097/PAT.0000000000000073.</citation>
    <PMID>24614712</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen G, Folpe AL, Colby TV, Sittampalam K, Patey M, Chen MG, Chan JK. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology. Mod Pathol. 2011 Dec;24(12):1560-70. doi: 10.1038/modpathol.2011.126. Epub 2011 Aug 5.</citation>
    <PMID>21822206</PMID>
  </results_reference>
  <results_reference>
    <citation>Noujaim J, Jones RL, Swansbury J, Gonzalez D, Benson C, Judson I, Fisher C, Thway K. The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities. Br J Cancer. 2017 Feb 28;116(5):669-678. doi: 10.1038/bjc.2017.4. Epub 2017 Jan 31.</citation>
    <PMID>28141799</PMID>
  </results_reference>
  <results_reference>
    <citation>Rossi S, Szuhai K, Ijszenga M, Tanke HJ, Zanatta L, Sciot R, Fletcher CD, Dei Tos AP, Hogendoorn PC. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res. 2007 Dec 15;13(24):7322-8.</citation>
    <PMID>18094413</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 22, 2018</study_first_submitted>
  <study_first_submitted_qc>November 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2018</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Histiocytoma</mesh_term>
    <mesh_term>Histiocytoma, Benign Fibrous</mesh_term>
    <mesh_term>Histiocytoma, Malignant Fibrous</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No Individual Patient Data sharing plan has been implemented</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT03759327/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

